PEGMGF (2mg)

PEG-MGF (2mg) protocols focus on this pegylated mechano growth factor (MGF), a splice variant of IGF-1, designed for extended half-life and localized tissue repair activity. It is studied for its potential role in supporting muscle recovery, satellite cell activation, and post-exercise tissue regeneration. This guide outlines a subcutaneous or localized administration approach optimized for the 2 mg vial format.

  • Reconstitute: Add 1.0 mL bacteriostatic water → 2 mg/mL concentration
  • Typical dosing range: 200–500 mcg per dose (subcutaneous or localized)
  • Easy measuring: At 2 mg/mL, 1 unit = 0.01 mL = 20 mcg on a U-100 insulin syringe
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks

Concise summary of the peptide regimen.

  • Goal: Support muscle repair, recovery, and localized tissue regeneration
  • Schedule: Administered post-workout or on rest days, depending on recovery needs
  • Dose Range: 200–500 mcg per injection

Suggested approach for the 2 mg vial format.

  • Start: 200 mcg per dose to assess tolerance
  • Target: 200–500 mcg per dose
  • Frequency: 1–3 times per week or post-training (localized or subcutaneous use)
  • Vial Duration: One 2 mg vial typically lasts 4–10 doses, depending on usage
  • Timing: Post-workout or immediately after muscle stress for localized effect

PEG-MGF (Pegylated Mechano Growth Factor) is a modified form of IGF-1 Ec (MGF) that has been pegylated to extend its half-life in circulation. MGF is naturally produced in response to mechanical overload or muscle damage and plays a key role in activating satellite cells, which are essential for muscle repair and growth.

The pegylation process slows degradation, allowing PEG-MGF to remain active longer in tissues. It is believed to enhance local muscle regeneration by increasing protein synthesis, stimulating satellite cell proliferation, and supporting repair of damaged muscle fibers. Preclinical research suggests it may be particularly active in post-exercise recovery and localized muscle repair processes.

Observations based on preclinical and early research use.

Potential Benefits:

  • May support faster muscle recovery after training
  • May enhance satellite cell activation and muscle repair
  • May improve localized muscle growth response
  • May support recovery from muscle injury or strain

Possible Side Effects:

  • Mild injection-site irritation
  • Temporary water retention in targeted areas
  • Headache or fatigue in some cases
  • Limited human clinical data; remains investigational